Symbiosal ® and lowering of blood pressure and reduced risk of hypertension: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006.

MLA

Turck, Dominique, et al. “Symbiosal ® and Lowering of Blood Pressure and Reduced Risk of Hypertension: Evaluation of a Health Claim Pursuant to Article 14 of Regulation (EC) No 1924/2006.” EFSA Journal, vol. 16, no. 7, July 2018, p. 1–N.PAG. EBSCOhost, https://doi.org/10.2903/j.efsa.2018.5364.

APA

Turck, D., Bresson, J.-L., Burlingame, B., Dean, T., Fairweather-Tait, S., Heinonen, M., Hirsch-Ernst, K. I., Mangelsdorf, I., McArdle, H. J., Naska, A., Neuhäuser-Berthold, M., Nowicka, G., Pentieva, K., Sanz, Y., Sjödin, A., Stern, M., Tomé, D., Van Loveren, H., Vinceti, M., & Willatts, P. (2018). Symbiosal ® and lowering of blood pressure and reduced risk of hypertension: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal, 16(7), 1–N.PAG. https://doi.org/10.2903/j.efsa.2018.5364

Chicago

Turck, Dominique, Jean-Louis Bresson, Barbara Burlingame, Tara Dean, Susan Fairweather-Tait, Marina Heinonen, Karen Ildico Hirsch-Ernst, et al. 2018. “Symbiosal ® and Lowering of Blood Pressure and Reduced Risk of Hypertension: Evaluation of a Health Claim Pursuant to Article 14 of Regulation (EC) No 1924/2006.” EFSA Journal 16 (7): 1–N.PAG. doi:10.2903/j.efsa.2018.5364.